FTRE - Fortrea Holdings - Stock Price & Dividends

Fortrea Holdings Inc., a leading contract research organization, specializes in providing comprehensive biopharmaceutical product and medical device development services to clients globally.

The company's operations are divided into two key segments: Clinical Services and Enabling Services. The Clinical Services segment offers a wide range of services across the clinical pharmacology and clinical development spectrum, from early-stage trials to late-stage studies.

The Enabling Services segment focuses on providing innovative patient access and clinical trial technology solutions that simplify complex randomization and optimize the trial drug supply process. This enables clients to streamline their clinical trials, reduce costs, and accelerate timelines.

Fortrea Holdings Inc. offers flexible delivery models to cater to diverse client needs, including full service, functional service provider, and hybrid service structures. This allows clients to choose the level of support they require, from comprehensive trial management to specific functional services.

The company's service portfolio is extensive, covering phase I-IV clinical trial management, technology-enabled trial solutions, and post-approval services. Additionally, Fortrea Holdings Inc. provides consulting services to help clients navigate the complex clinical trial landscape.

Fortrea Holdings Inc. serves a diverse range of clients, including pharmaceutical, biotechnology, and medical device organizations. With its headquarters in Durham, North Carolina, the company is well-positioned to support clients across the globe.

For more information, please visit Fortrea Holdings Inc.'s website at https://www.fortrea.com.